Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis, IGA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00446251
What this trial is testing

Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicDiabetic NephropathiesGlomerulonephritis, IGA+1 more
University of Washington 14
Testing effectiveness (Phase 2)Study completedNCT00767221
What this trial is testing

Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

Who this might be right for
IGA Nephropathy
Calliditas Therapeutics AB 20
Large-scale testing (Phase 3)Study completedNCT02232776
What this trial is testing

Efficacy and Safety of Losartan in Children With Ig A Nephropathy

Who this might be right for
Glomerulonephritis, IGA
Seoul National University Hospital 37
Early research (Phase 1)Study completedNCT03719443
What this trial is testing

First in Human Study to Assess Safety of VIS649 in Healthy Subjects

Who this might be right for
Immunoglobulin A NephropathyIgAN - IgA NephropathyIgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. 51
Post-approval studies (Phase 4)WithdrawnNCT02382523
What this trial is testing

Acthar on Proteinuria in IgA Nephropathy Patients

Who this might be right for
IgA NephropathyProteinuria
Baylor College of Medicine
Testing effectiveness (Phase 2)Study completedNCT03366337
What this trial is testing

Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX

Who this might be right for
IgA NephropathyCKD Associated With Type 1 DiabetesFocal Segmental Glomerulosclerosis+1 more
Biogen 103
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06635772
What this trial is testing

The Effect and Safety of HS-10390 in the Treatment of Patients with Primary IgA Nephropathy

Who this might be right for
Immunoglobulin a Nephropathy
Hansoh BioMedical R&D Company 90
Testing effectiveness (Phase 2)Study completedNCT02942381
What this trial is testing

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

Who this might be right for
IgA PatientsHydroxychloroquine
Peking University First Hospital 60
Post-approval studies (Phase 4)UnknownNCT00862693
What this trial is testing

Calcitriol in the Treatment of Immunoglobulin A Nephropathy

Who this might be right for
GlomerulonephritisAutoimmune Diseases
Peking University First Hospital 40
Not applicableStudy completedNCT07617402
What this trial is testing

Exploring the Brain - Gut Microbiota - Kidney Interactive Damage Mechanisms Underlying Cognitive Decline in Patients With IgA Nephropathy Using Ultra-high Field Magnetic Resonance Imaging

Who this might be right for
IgA Nephropathy (IgAN)
Tang-Du Hospital 200
Not applicableStudy completedNCT00004305
What this trial is testing

Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis

Who this might be right for
IGA Glomerulonephritis
National Center for Research Resources (NCRR) 105
Not applicableUnknownNCT05132621
What this trial is testing

The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy.

Who this might be right for
Systemic Lupus ErythematosusImmunoglobulin A Nephropathy
Medical University of Warsaw 150
Not applicableLooking for participantsNCT03929887
What this trial is testing

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Who this might be right for
Glomerular DiseaseMinimal Change DiseaseIgA Nephropathy+4 more
Seoul National University Hospital 3,000
Not applicableWithdrawnNCT07022574
What this trial is testing

Autoimmune Protocol Diet Intervention on Proteinuria in IgA Nephropathy Patients

Who this might be right for
IgA Nephropathy (IgAN)
University of California, Los Angeles
Post-approval studies (Phase 4)Study completedNCT01115426
What this trial is testing

Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

Who this might be right for
IGA Glomerulonephritis
University Magna Graecia 20
Not applicableEnded earlyNCT00885547
What this trial is testing

Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis

Who this might be right for
IgA Nephropathy
Nanjing University School of Medicine 90
Testing effectiveness (Phase 2)Study completedNCT02384317
What this trial is testing

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

Who this might be right for
Immunoglobulin A Nephropathy
Amgen 7
Large-scale testing (Phase 3)UnknownNCT04833374
What this trial is testing

Steroids Therapy in IgA Nephropathy With Crescents

Who this might be right for
IgA Nephropathy
Sixth Affiliated Hospital, Sun Yat-sen University 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07770815
What this trial is testing

Trial of Sibeprenlimab in Children and Adolescents With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy
Otsuka Pharmaceutical Development & Commercialization, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Next Page